Moderna’s vaccine is the first coronavirus vaccine to be tested in humans. (David L Ryan/Boston Globe via Getty Images)European stocks climbed on Wednesday as investors assessed positive results from initial trials of an experimental coronavirus vaccine produced by biotechnology firm Moderna (MRNA).The potential vaccine, developed by researchers at the US National Institute of Allergy and…

Coronavirus is linked to several neurological conditions, including stroke, delirium, nerve damage and a rare inflammatory brain condition that can be fatal, according to a new study.“We should be vigilant and look out for these complications in people who have had COVID-19,” Dr. Michael Zandi of University College London’s Queen Square Institute of Neurology and joint…

NEW YORK: What is this enemy? Seven months after the first patients were hospitalized in China battling an infection doctors had never seen before, the world's scientists and citizens have reached an unsettling crossroads. Countless hours of treatment and research, trial and error now make it possible to take much closer measure of the new…

Moderna's COVID-19 vaccine generates positive, promising immune response - KOMO News

TUCSON, Ariz. — Quality of Life Medical and Research Center in Tucson will be one of 87 clinics nationwide conducting Phase 3 trials of Moderna's mRNA-1273 COVID-19 vaccine. The study will look at 30,000 adult participants at high risk of contracting the coronavirus. The trial is now expected to begin July 27. The mRNA-1273 vaccine…